fregime

What actually happened to the stocks you care about: every claim cited, corroboration counted, never opinions.

SPARC · NSE

Sun Pharma Advanced Research Company

₹194.36

-0.05%

Close (EOD), as of 26 Aug 2026 · source

Not in active coverage. Cited reporting has mentioned Sun Pharma Advanced Research Company, the record of those mentions is below. Your interest is logged; coverage expands by demand.

Mentions in cited reporting

Sun Pharma Advanced Research Company reported consolidated net sales of Rs 39.92 crore in June 2026, up 314.11% year-over-year from Rs 9.64 crore in June 2025.

moneycontrol.comsingle-source report20 Aug 2026

Every claim carries its citation

This page lists where cited reporting has mentioned Sun Pharma Advanced Research Company. It is not the full dossier: developments here are single mentions, not corroborated records. We compile and cite; we do not opine.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.